tiprankstipranks
Tourmaline Bio, Inc. Reports Third Quarter Financial Results
PremiumCompany AnnouncementsTourmaline Bio, Inc. Reports Third Quarter Financial Results
1M ago
Tourmaline Bio price target raised to $49 from $48 at H.C. Wainwright
Premium
The Fly
Tourmaline Bio price target raised to $49 from $48 at H.C. Wainwright
1M ago
Tourmaline Bio files $350M mixed securities shelf
Premium
The Fly
Tourmaline Bio files $350M mixed securities shelf
1M ago
Tourmaline Bio management to meet with Truist
PremiumThe FlyTourmaline Bio management to meet with Truist
2M ago
Tourmaline Bio’s Chief Medical Officer Resigns Amicably
Premium
Company Announcements
Tourmaline Bio’s Chief Medical Officer Resigns Amicably
2M ago
Tourmaline Bio forms Cardiovascular Scientific Advisory Board
Premium
The Fly
Tourmaline Bio forms Cardiovascular Scientific Advisory Board
3M ago
Tourmaline Bio Appoints Ryan Robinson as CFO and Treasurer
PremiumCompany AnnouncementsTourmaline Bio Appoints Ryan Robinson as CFO and Treasurer
6M ago
Tourmaline Bio promotes Robinson to Chief Financial Officer
Premium
The Fly
Tourmaline Bio promotes Robinson to Chief Financial Officer
6M ago
Tourmaline Bio announces first patient dosed in Phase 2 TRANQUILITY trial
Premium
The Fly
Tourmaline Bio announces first patient dosed in Phase 2 TRANQUILITY trial
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100